Meghan Duncan, CCRP

Meghan Duncan has extensive experience in the clinical operations field. Meghan is currently the Director of Clinical Operations at Xilio Therapeutics, Inc., a position they have held since January 2022. Prior to this, Meghan worked as the Associate Director of Clinical Operations at Xilio Therapeutics from April 2021 to December 2021. Before joining Xilio Therapeutics, Meghan served as the Associate Director of Clinical Operations at Syndax Pharmaceuticals from June 2020 to March 2021.

Meghan also has experience at TESARO, Inc., where they worked as a Senior Clinical Trial Manager from January 2019 to May 2020, and as a Clinical Trial Manager from December 2014 to December 2018. Additionally, they worked at Brigham and Women's Hospital as a Clinical Trial Protocol Lead for the TIMI Study Group from December 2013 to November 2014.

Earlier in their career, Meghan held roles at Sirtris, a GSK Company, including Clinical Research/Senior Associate Scientist from November 2012 to July 2013, Associate Scientist from November 2010 to November 2012, and Assistant Scientist from May 2007 to November 2010. Meghan began their career as a Research Assistant at Charles River Laboratories from June 2005 to May 2007.

Overall, Meghan's work experience spans various positions in clinical operations at both pharmaceutical companies and research institutions, highlighting their expertise and dedication in the field.

Meghan Duncan, CCRP has a strong educational background in the field of clinical research. In 2001, they began their studies at the University of Massachusetts Amherst, where they pursued a Bachelor of Science degree in Biology. After completing their undergraduate education in 2005, Meghan furthered their knowledge by earning a CRA/CRC Certificate in Clinical Research from Boston College in 2013. To enhance their professional credentials, they obtained additional certifications including the Certified Clinical Research Professional from SOCRA in 2016 and the LATG certification from AAALAC International in 2013. Overall, Meghan's education history reflects a focused dedication to the field of clinical research and a commitment to expanding their expertise.